Spasmodic dysphonia is a neurological disorder characterized by speech impediments that occur due to involuntary contractions of the vocal cords and surrounding muscles. This results in an abnormal timbre of the voice, which may be hoarse, choppy, or lisping, as well as difficulty speaking. Spasmodic dysphonia can occur both in solitary speech and in the course of communication, which significantly affects the quality of life of patients and their social interactions. This disease is often classified as a dystonia, since its main manifestation is involuntary movement disorders that affect the larynx and vocal apparatus.
History of the disease and interesting historical facts
Spasmodic dysphonia was first described in medical literature as a specific voice disorder in the late 19th century. One of the earliest cases was documented by German neurologist Karl Wilhelm Trepo, who noticed the phenomenon of involuntary contraction of the vocal cords in his patients. Over time, spasmodic dysphonia attracted the attention of many specialists, including ENT doctors, neurologists, and speech therapists. In the 1980s, treatment methods including botulinum therapy began to be actively used, which gave a new impetus to the field of rehabilitation of patients with this disorder. Interestingly, during the 20th century, the technology of diagnosis and treatment of spasmodic dysphonia underwent significant changes, which allowed for a better understanding of the mechanisms of the disease.
Epidemiology
According to epidemiological studies, the prevalence of spasmodic dysphonia is approximately 1-2 cases per 1000 people. The disease occurs in both men and women, with a slight predominance among the latter. The incidence may increase with age, usually starting from the age of 30-40. Risk groups include people working in professions associated with intensive vocal stress, such as teachers, singers and actors. An important aspect is that the number of cases of spasmodic dysphonia remains stable despite improvements in diagnostics and availability of medical services.
Genetic predisposition to this disease
Studies of genetic predisposition to spasmodic dysphonia point to the possible involvement of genes such as DYT6, DYT11 and others responsible for the regulation of motor functions. To date, it has been proven that mutations in these genes may be associated with the development of dystonias, including spasmodic dysphonia. Studies show that about 20% patients with spasmodic dysphonia have a family history of dystonia, which may indicate the presence of autosomal dominant inheritance. However, genetic factors are not the only determining factors, and environmental and other factors play an important role.
Risk factors for the development of this disease
Risk factors for spasmodic dysphonia are varied and may fall into the following categories:
- Physical factors: prolonged and excessive use of the voice, excessive tension of the vocal cords.
- Chemical factors: exposure of the vocal cords to toxic substances or chemical irritants, such as tobacco smoke.
- Psychological factors: Emotional stress and psychological trauma can contribute to the aggravation of symptoms of the disease.
- Neurological disorders: The presence of other dystonias or neurological diseases may increase the risk of developing spasmodic dysphonia.
Diagnosis of this disease
Diagnosis of spasmodic dysphonia involves several key steps. The main symptoms of the disease include:
- A hoarse and broken voice.
- Difficulty pronouncing certain sounds or words.
- Involuntary tension in the neck and larynx during speech.
Laboratory tests may be ordered to rule out infections, inflammations, or other diseases. Radiological tests, such as MRI, may be used to visualize structural changes in the larynx. Other diagnostics may include endoscopic examination to evaluate the vocal cords. The differential diagnosis includes laryngospasm, vocal cord fibrosis, and other neurological disorders.
Treatment
Treatment of spasmodic dysphonia can be complex and multi-level. Conservative methods include:
- Pharmacological treatments include botulinum toxins to temporarily paralyze the muscles causing the spasms.
- Speech therapy aimed at improving speech technique and relaxing the muscles of the larynx.
- Physical therapy to improve overall coordination and reduce muscle tension.
In some cases, surgical treatment may be necessary when conservative methods prove ineffective. Surgical interventions may include vocal cord surgery to eliminate hypertonicity. New treatments, such as cell transfer, are currently being studied.
List of medications used to treat this disease
The main medications used to treat spasmodic dysphonia include:
- Botulinum toxins type A (eg, Botox, Dysport).
- Antidepressants (to reduce stress and improve mood).
- Muscle relaxants (to reduce muscle tension).
Dosages and treatment regimens are selected individually depending on the severity of the disease and the response to therapy.
Disease monitoring
Monitoring the condition of a patient with spasmodic dysphonia includes regular control steps, such as:
- Evaluation of the effectiveness of the prescribed treatment.
- Check for the appearance of new symptoms or exacerbation of chronic manifestations.
- Regular consultations with a speech therapist and neurologist.
The prognosis for patients can vary: some may experience significant improvement, while others may experience persistent or worsening symptoms. Complications of spasmodic dysphonia may include the development of depression due to social isolation and decreased quality of life.
Age-related features of the disease
Spasmodic dysphonia can manifest itself in different age groups, and the course of the disease varies depending on the patient's age. In young people and adults, the disease can develop faster, sometimes after intense strain on the voice. In older people, spasmodic dysphonia can be associated with other diseases, such as Parkinson's disease, which complicates treatment and requires a multidisciplinary approach. It is important to take age-related features into account when choosing methods of therapy and rehabilitation.
Questions and Answers
- What is spasmodic dysphonia? Spasmodic dysphonia is a neurological disorder characterized by speech impediments due to involuntary contractions of the vocal cords.
- What are the main causes of spasmodic dysphonia? The main causes include genetic predisposition, long-term use of the voice and stress.
- How is spasmodic dysphonia diagnosed? Diagnosis includes assessment of symptoms, laboratory tests, radiological examinations, and endoscopic examination of the larynx.
- How is spasmodic dysphonia treated? Treatment may include drug therapy, speech therapy, and in some cases surgery.
- What is the prognosis for patients with spasmodic dysphonia? The prognosis can vary: some patients experience significant improvement, but in others, symptoms may persist.
